Followers | 36 |
Posts | 3729 |
Boards Moderated | 0 |
Alias Born | 07/08/2002 |
Friday, May 24, 2024 7:12:49 AM
We all know now that Amarex essentially "cooked the books" in a seriously negative way because it claimed that CYDY did not pay them, which was not the case due to the ongoing lawsuit and its related court documents.
From these trials, there were enough positive outcomes and even some who were literally on their Covid deathbeds rose from the dead. There were reports of some that had other illnesses beside Covid that vanished within weeks. Hearsay is a problem; however, Jay Lalezari, the CYDY CEO is convinced of the merits of Leronlimab and as "Learning53" wrote 'doesn't appear to have any significant long term side-effects.' Incidentally or THANK HEAVENS, Dr. Lalezari terminated his Quest Diagnostics full time career and is now the CYDY CEO. Who needs to worry now?
There was a trial in Florida for patients with long Covid who courageously volunteered knowing that they might take the placebo for the entire trial, and there were those who were fortunate to be given Leronlimab. The result was what we already knew and hoped, they got better, but when the trial ended and they soon found out that Leronlimab would be discontinued, as "Learning53" aptly described, those trial patients descended into hell 'And PRAY Leronlimab is available when it's the only thing that might stand between you and torment.'
There are so many diseases today that torment people. Leronlimab has been with us for about 20 years. Every step of the way, it has met severe obstruction. Many on this board can attest to that statement by investing heavily in this company only to be fleeced not only by the officers in the company but by the CRO management and by others who shall remain as nameless as an old tombstone in the desert.
If you have not witnessed torment in others, then I hope you will be surprised when someone is administered Leronlimab. Torment comes in ways that is hard to fathom until it is taken away: by memory, by internal-debilitating sickness, respiratory complications, and the top rat HIV and its sickening myriad complexities. I do not mean to take this lightly in my description because I have not experienced the above but have heard the pleas of those who have been administered Leronlimab. Yes, one can say it was something else that helped them but I will disagree now. Look what Dr. Lalezari did. He left a real paying job to liberate the sick with the only MAB that CYDY possesses. A one trick pony company. Watch it win the races.
Recent CYDY News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 09:15:10 PM
- Form SC TO-I - Tender offer statement by Issuer • Edgar (US Regulatory) • 06/03/2024 09:10:56 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:17:30 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2024 09:16:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 09:09:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:30:20 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:16:47 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/01/2024 10:15:34 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 02/22/2024 10:16:11 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/22/2024 05:15:08 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 02:00:24 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:31:57 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/29/2024 10:22:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 01:40:14 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/19/2024 10:15:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/16/2024 10:16:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:04:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2024 02:02:30 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM